BIOAGE LABS, INC. Basic Shares Outstanding (Weighted Average)
BIOAGE LABS, INC. (BIOA) reported Basic Shares Outstanding (Weighted Average) of 44.84 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- BIOAGE LABS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 44.84M shares, a 25.07% increase year-over-year.
- BIOAGE LABS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 42.48M shares, a 18.49% increase year-over-year.
- BIOAGE LABS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 36.18M shares, a 0.47% increase year-over-year.
- BIOAGE LABS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 35.85M shares, a 925.88% increase year-over-year.
- BIOAGE LABS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 35.93M shares, a 234.99% increase from fiscal 2024.
- BIOAGE LABS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 10.73M shares, a 541.23% increase from fiscal 2023.
- BIOAGE LABS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 1.67M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 44.84M shares 10-Q · filed 2026-08-05 | 43.67M shares 10-Q · filed 2026-08-05 | 41.17M shares derived: average of 3 quarters · filed 2026-08-05 | 39.84M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 42.48M shares 10-Q · filed 2026-05-08 | 39.33M shares derived: average of 2 quarters · filed 2026-05-08 | 38.17M shares derived: average of 3 quarters · filed 2026-05-08 | 37.59M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 36.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 36.02M shares derived: average of 2 quarters · filed 2026-03-24 | 35.96M shares derived: average of 3 quarters · filed 2026-08-05 | 35.93M shares 10-K · filed 2026-03-24 |
| 2025-09-30 | 35.85M shares 10-Q · filed 2025-11-06 | 35.85M shares derived: average of 2 quarters · filed 2026-08-05 | 35.85M shares 10-Q · filed 2025-11-06 | 35.89M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 35.85M shares 10-Q · filed 2026-08-05 | 35.85M shares 10-Q · filed 2026-08-05 | 35.90M shares derived: average of 3 quarters · filed 2026-08-05 | 27.80M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 35.85M shares 10-Q · filed 2026-05-08 | 35.93M shares derived: average of 2 quarters · filed 2026-05-08 | 25.12M shares derived: average of 3 quarters · filed 2026-05-08 | 19.27M shares derived: average of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | 36.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 19.75M shares derived: average of 2 quarters · filed 2026-03-24 | 13.74M shares derived: average of 3 quarters · filed 2026-03-24 | 10.73M shares 10-K · filed 2026-03-24 |
| 2024-09-30 | 3.49M shares 10-Q · filed 2025-11-06 | 2.60M shares derived: average of 2 quarters · filed 2025-11-06 | 2.30M shares 10-Q · filed 2025-11-06 | 2.14M shares derived: average of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | 1.71M shares 10-Q · filed 2025-08-06 | 1.69M shares 10-Q · filed 2025-08-06 | 1.69M shares derived: average of 3 quarters · filed 2025-08-06 | 1.68M shares derived: average of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | 1.67M shares 10-Q · filed 2025-05-06 | 1.67M shares derived: average of 2 quarters · filed 2025-05-06 | 1.67M shares derived: average of 3 quarters · filed 2025-05-06 | |
| 2023-12-31 | 1.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 1.67M shares derived: average of 2 quarters · filed 2025-03-20 | 1.67M shares 10-K · filed 2025-03-20 | |
| 2023-09-30 | 1.67M shares 10-Q · filed 2024-11-07 | 1.67M shares 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |